An Evaluation Of Losmapimod in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Systemic Inflammation Stratified Using Fibrinogen (EVOLUTION).
Phase of Trial: Phase II
Latest Information Update: 18 May 2016
At a glance
- Drugs Losmapimod (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms EVOLUTION
- 10 Jun 2017 Biomarkers information updated
- 18 May 2016 Primary endpoint has not been met. (Endothelial function as measured by flow mediated dilatation), as per results presented at the 112th International Conference of the American Thoracic Society.
- 18 May 2016 Primary endpoint has not been met. (Vascular inflammation on FDG PET-CT), as per results presented at the 112th International Conference of the American Thoracic Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History